http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
AmeraMex International Hosts Conference Call for Its Third Quarter Ending September 30, 2024
-
Allarity Therapeutics (ALLR) Reports Key Progress in Phase 2 Stenoparib Trial
-
Eight Royal Families of Europe and Africa Collaborate to Bring New Online Video Game, TheRoyal.Land, to Market
-
LEXUS MARKS 25 YEARS OF ITS ICONIC "DECEMBER TO REMEMBER" CAMPAIGN
-
Premium Resources Ltd. Announces Name Change
-
Lumentum Announces Upcoming Investor Events
-
City National Entertainment CEO Kelly Coffey Joins Operation HOPE Global Board of Advisors
-
Passenger count at Ontario International Airport increased for 44th straight month in busiest October ever
-
Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements
-
BlackRock Expands Investor Access to International Equities with New Active ETF
-
Convergent Therapeutics Announces First Shipments of Actinium 225 from Cardinal Health to Support the CONVERGE-01 Phase 2 Clinical Trial
-
Green Leaf Innovations, Inc. Achieves Over 2,200% Revenue Growth Year-Over-Year
-
Exact Sciences Partners with Actor and TV Personality Carlos Ponce to Increase Awareness of Colon Cancer Screening Among Hispanic Community
-
Edison XFC Recognized as a Top 10 EV Charging Solutions Provider
-
2025 Nissan Armada Delivers Full-Size Adventures From $56,520
-
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Compl
-
Alta Copper Adds to Management Team
-
CBIH Strengthens Clinical Research Team in Preparation for Launch of Next-Generation Cannabinoid Solutions
-
Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate
-
Cryptonica Announces Date for Global Conference in Cape Town, Unveiling Ambitious Plans and Innovations
-
BAN (Comedian), a Meme Coin, Has Listed on CoinW Exchange
-
Zimmer Biomet (ZBH) Announces CE Mark Certification for Persona® Revision Knee System
-
Arrowhead Pharmaceuticals Inc. (ARWR) Submits New Drug Application to U.S. FDA for Plozasiran
-
Arrowhead Pharmaceuticals (ARWR) Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran
-
Arrowhead Pharmaceuticals Submits New Drug Application to U.S. FDA for Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
-
Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
-
Arrowhead Pharmaceuticals Presents New Data at AHA24 from PALISADE Phase 3 Study and Open-Label Extension from MUIR and SHASTA-2 Studies of Plozasiran
-
Eminent Gold Commences Drilling on Getchell Trend Analogue in Nevada
-
Capstan Therapeutics Presents Preclinical Data on Lead In Vivo CAR-T Candidate, CPTX2309, at American College of Rheumatology (ACR) Convergence 2024
-
Halozyme Therapeutics (HALO) Provides Update on Non-Binding Proposal to Combine with Evotec (EVO)
-
Wolfspeed (WOLF) says Gregg Lowe will depart from his roles as President and CEO
-
Serve Robotics (SERV) Appoints Anthony Armenta as Chief Software & Data Officer
-
AFL Global Automates Energy Management and Anticipates $304K of Savings in First Year with EnergyCAP
-
Wolfspeed Announces Leadership Transition
-
Kobo Resources Extends Highly Prospective Jagger Zone by 250 m South with Strong New Gold Intercepts, Including 7.0 m at 3.66 g/t Au and 4.0 m at 3.26 g/t Au
-
monday.com Announces Participation in the 51st Nasdaq London Investor Conference
-
Bitdeer Reported Unaudited Financial Results for the Third Quarter of 2024
-
Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec
-
Serve Robotics Appoints Anthony Armenta as Chief Software & Data Officer
-
Gold79 Closes Second Tranche of Upsized Private Placement for Gross Proceeds of $5.5 Million
-
PreveCeutical's Subsidary, Biogene Therapeutics Announces Strategic Appointments: Dr. Linnea Olofsson as Chief Scientific Officer and Dr. Harry Parekh as Chief Research Officer
-
Kandi Technologies Reports Third Quarter 2024 Financial Results
-
BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH
-
Aurania to Attend Deutsche Goldmesse in Frankfurt, November 22, 2024
-
Automated Logistics Systems Simplifies Customs Clearance with Descartes Foreign Trade Zone Solution
-
CoolIT Announces the World's Highest Density Liquid-to-Liquid Coolant Distribution Unit
-
Greenwich LifeSciences Provides Update on Corporate Events
-
Blue Sky Uranium Presents in Red Cloud's Virtual Webinar Series
-
Bernstein SocGen Group Reiterates Underperform Rating on Tesla (TSLA), PT $120
-
BridgeBio Pharma Announces Publication in the New England Journal of Medicine of Phase 2 PROPEL 2 Study of Infigratinib for Children Living with Achondroplasia


